☆ 4.6 Review

Gastric Cancer and the Immune System: The Key to Improving Outcomes?

CANCERS (2022)

Related references

Note: Only part of the references are listed.

Review Gastroenterology & Hepatology

Trends of stomach cancer survival: A systematic review of survival rates from population-based cancer registration

Jia Yi Tuo et al.

Summary: This study examined the survival patterns and trends of stomach cancer worldwide using population-based cancer registers. The results showed that the survival rates of stomach cancer have improved globally over time, although the increase was not significant. Japan had the highest 5-year survival rate, while Africa and India had relatively poor rates. Survival rates were higher in women than in men in America, Europe, and Oceania, but lower in Asia. Older patients aged over 75 years had the poorest survival rates.

JOURNAL OF DIGESTIVE DISEASES (2022)

Add to Collection

Review Oncology

Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2D gastroesophageal adenocarcinoma

D. V. T. Catenacci et al.

Summary: This article summarizes 23 studies on the safety and efficacy of trastuzumab with doublet chemotherapy in HER2+ gastroesophageal adenocarcinoma patients. The results show that this treatment regimen has good clinical outcomes in patients with locally advanced unresectable or metastatic GEA.

ESMO OPEN (2022)

Add to Collection

Review Oncology

The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials

Marco Dubois et al.

Summary: This study conducted a meta-analysis to evaluate the efficacy of immune checkpoint inhibitors in patients with gastric/gastroesophageal cancer. The results showed that the use of immune checkpoint inhibitors could significantly reduce the risk of death and disease progression in these patients. Regardless of the patients' combined positive score, the combination of immune checkpoint inhibitors with standard first-line chemotherapy could be considered for treatment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Add to Collection

Article Oncology

MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

Yelena Y. Janjigian et al.

Summary: This study investigates the efficacy and safety of the immune checkpoint inhibitor durvalumab combined with FLOT chemotherapy in patients with resectable gastric/gastroesophageal junction cancer, and finds that the combination therapy improves clinical outcomes.

FUTURE ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi et al.

Summary: The interim analysis results of a phase 1 clinical trial show that CLDN18.2-targeted CAR T cell therapy has promising efficacy and an acceptable safety profile in previously treated, CLDN18.2-positive digestive system cancer patients. Particularly, it shows significant efficacy in patients with gastric cancer.

NATURE MEDICINE (2022)

Add to Collection

Review Cell Biology

Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer

Lin Zhao et al.

Summary: Metabolic disorders and abnormal immune function changes occur in tumor tissues and cells. Reprogrammed energy metabolism affects the development of tumor suppressive immune microenvironment and the progression of gastric cancer (GC). The tumor microenvironment (TME) has important clinical and pathological significance in predicting prognosis and therapeutic efficacy. Understanding the targeted metabolism of metabolic reprogramming can enhance anti-tumor immune responses and provide direction for the treatment and prognosis of GC.

CELL DEATH & DISEASE (2022)

Add to Collection

Article Genetics & Heredity

TGFβ-Associated Signature Predicts Prognosis and Tumor Microenvironment Infiltration Characterization in Gastric Carcinoma

Siyuan Liu et al.

Summary: A TGF beta-associated signature has been developed and validated, which is capable of predicting the survival outcome and depicting the tumor microenvironment immune characteristics in gastric carcinoma (GC).

FRONTIERS IN GENETICS (2022)

Add to Collection

Review Oncology

Research Progress of Antibody-Drug Conjugate Therapy for Advanced Gastric Cancer

Na Wang et al.

Summary: Gastric cancer is a prevalent and difficult-to-treat malignant tumor. Antibody-drug conjugates hold promise as a novel therapeutic option, but drug resistance is a challenge.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Immunology

Regulatory T-cell development in the tumor microenvironment

Kota Itahashi et al.

Summary: Treg cells play a crucial role in maintaining self-tolerance and preventing the development of autoimmune diseases. However, in tumors, there is an abundance of Treg cells that suppress antitumor immunity, promoting tumor development and growth. Therefore, understanding tumor-infiltrating Treg cells is essential for the development of Treg cell-targeted therapies.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Add to Collection

Review Immunology

The complex role of tumor-infiltrating macrophages

Anthos Christofides et al.

Summary: This article reviews the characteristics of tumor-associated macrophages (TAMs) and discusses the mechanisms that contribute to their pathological adaptations to the tumor microenvironment. TAMs play a crucial role in the tumor microenvironment and are closely associated with cancer progression.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Profiling the Tumor-Infiltrating Lymphocytes in Gastric Cancer Reveals Its Implication in the Prognosis

Weiqiang Yu et al.

Summary: Gastric cancer is a common malignancy and a leading cause of cancer-related mortality. This study analyzed the composition of tumor-infiltrating lymphocytes (TILs) in gastric cancer patients and found that the profiles of TILs have the potential to predict patients' immune cell profiles and prognosis outcomes.

GENES (2022)

Add to Collection

Review Immunology

When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4+ T Cells

Cindy Hoeks et al.

Summary: CD4 CTL, once considered an experimental artefact, are now recognized as a biologically relevant T cell subset with important functions in anti-viral, anti-tumor, and autoimmune responses. With the advancement of single cell analysis techniques, the study of CD4 CTL has been facilitated. This review summarizes the developmental path of CD4 CTL and presents markers for their detection and isolation. The subsets of CD4 CTL and their diverse functionalities are discussed.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology

Tushar Garg et al.

Summary: This review discusses different techniques for evaluating the immune microenvironment of tumors, analyzing the collected data, and its relevance to patient care. Image-guided tissue sampling is crucial for cancer patients receiving immunotherapy. Interventional radiologists play a significant role in evaluating these patients.

CANCERS (2022)

Add to Collection

Article Oncology

The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer

Jiajia Yuan et al.

Summary: In this study, the immune cell features in gastric cancer patients were analyzed using multiplexed immunohistochemistry and digital image analysis. The association of blood indexes with the primary gastric cancer immune microenvironment was also examined. The results showed that blood indexes were associated with immune cells infiltrating in primary tumors of gastric cancer, and NLR and LMR were related to the prognostic values of immunotherapy.

CANCERS (2022)

Add to Collection

Article Oncology

Immunotherapy in Gastric Cancer

Anica Hoegner et al.

Summary: Immune checkpoint inhibition is a new standard of targeted therapy in the treatment of advanced or metastatic gastric cancer. Clinical trials have shown that combination therapy with immune checkpoint inhibitors and chemotherapy or targeted therapy can improve overall survival in patients at different treatment stages.

CURRENT ONCOLOGY (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Antibody-drug conjugates to treat gastric cancer

Shigehiro Koganemaru et al.

Summary: Despite new treatment options, the long-term prognosis of recurrent or inoperable gastric cancer remains poor. Antibody-drug conjugates (ADCs) have shown promising results in clinical trials. Novel HER2-ADCs have led to breakthrough results for HER2(+) gastric cancer, but there are still questions that need to be addressed, especially in clinical settings. Translational research to elucidate ADCs' mechanisms of action or resistance will lead to more sophisticated use of ADCs and combination strategies.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Add to Collection

Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Review Medicine, Research & Experimental

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

Sreya Bagchi et al.

Summary: This article highlights the significance of immune checkpoint inhibitors in cancer immunotherapy and the research findings on the changes in local and systemic immune cells after treatment. It emphasizes the need for understanding the requirements for an effective and safe antitumor immune response following ICI therapy.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)

Add to Collection

Review Infectious Diseases

CAR-T cell therapy and infection: a review

Olivia Bupha-Intr et al.

Summary: Patients undergoing CAR-T cell therapy are at increased risk of infection due to prior immunosuppression and treatment-specific toxicities, highlighting the importance of infection prevention strategies. Ongoing surveillance and effective prophylaxis are essential to support safe and effective patient care in the rapid adoption of CAR-T cell therapy.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

Add to Collection

Review Oncology

MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma

Daniel V. T. Catenacci et al.

Summary: This study describes the design and rationale of a clinical trial evaluating the use of margetuximab plus retifanlimab or margetuximab plus tebotelimab in unresectable metastatic/locally advanced gastric/gastroesophageal junction adenocarcinoma as first-line therapy. Primary endpoints include objective response rate, overall survival, and safety/tolerability.

FUTURE ONCOLOGY (2021)

Add to Collection

Article Immunology

Tumor-infiltrating B cell is associated with the control of progression of gastric cancer

Zhonglin Ni et al.

Summary: The study found that B cell infiltration, especially class-switched memory B cells and plasma cells, in gastric cancer has a significant impact on tumor progression and prognosis. High levels of CD20+ B cell infiltration were significantly associated with improvements in overall survival and disease-free survival.

IMMUNOLOGIC RESEARCH (2021)

Add to Collection

Review Oncology

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials

Anwaar Saeed et al.

Summary: Various targeted therapies, including anti-angiogenic agents and immune checkpoint inhibitors, have shown efficacy in patients with advanced gastric cancer and gastroesophageal junction adenocarcinoma. Combining VEGF inhibition with immune checkpoint blockade has shown promising clinical activity, indicating a potential dual blockade strategy in this patient population.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Review Oncology

Tumor-Infiltrating Natural Killer Cells

Beatriz Cozar et al.

Summary: NK cells play a crucial role in immune responses to tumors by killing target cells and producing cytokines, but they can become dysfunctional in the immunosuppressive tumor microenvironment. This article provides an overview of NK tumor infiltration and surveillance, as well as the mechanisms by which NK cells become dysfunctional.

CANCER DISCOVERY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Immune Cell Landscape in Gastric Cancer

Yang Yang et al.

Summary: The study identified changes in immune cell composition between gastric cancer tissues and normal tissues. Certain immune cells, such as macrophages and Tregs, were found to be associated with gastric cancer prognosis. Additionally, the expression of immune regulatory factors in gastric cancer tissues did not follow their classical function, with some factors being overexpressed while others were underexpressed.

BIOMED RESEARCH INTERNATIONAL (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Medicine, Research & Experimental

Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center

Ming-zhi Xie et al.

Summary: In this study involving 180 gastric cancer patients, it was found that patients with a higher percentage of NK cells had longer survival times and could serve as an independent prognostic indicator for gastric cancer. NK cell percentage was positively correlated with lymphocyte count and albumin, while negatively correlated with CA125 and neutrophil-lymphocyte ratio. NK cells showed predictive value for the 5-year survival rate of gastric cancer, especially when combined with neutrophil-lymphocyte ratio. Patients at early T, N, and clinical stages tended to have a higher percentage of NK cells compared to those at advanced stages.

MEDICAL SCIENCE MONITOR (2021)

Add to Collection

Article Immunology

An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer

Hongfei Yan et al.

Summary: An immune signature based on infiltrating immune cells composition was established to predict survival and chemotherapy benefits for gastric cancer patients after surgery. The IS classifier consisting of eight immune cells showed significant prognostic value, especially when combined with TNM stage. Patients with high-IS were more likely to benefit from a specific chemotherapy regimen, and two nomograms were established to screen for suitable patients for adjuvant chemotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Oncology

CAR-T cell therapy: current limitations and potential strategies

Robert C. Sterner et al.

Summary: CAR-T cell therapy has shown remarkable clinical responses in certain subsets of leukemia or lymphoma, but faces challenges in solid tumors and hematological malignancies. Innovative strategies and approaches are necessary to overcome these challenges and improve the efficacy of CAR-T cells.

BLOOD CANCER JOURNAL (2021)

Add to Collection

Article Oncology

Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials

Joseph Chao et al.

Summary: This study indicates that MSI-H status may serve as a biomarker for pembrolizumab therapy in advanced G/GEJ cancer patients regardless of the line of therapy.

JAMA ONCOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

CAR-T cells: Early successes in blood cancer and challenges in solid tumors

Hassan Dana et al.

Summary: New approaches in cancer immunotherapy, such as checkpoint inhibitors for solid tumors and CAR-T cell therapy for hematologic malignancies, have shown promising results. While CAR-T products have demonstrated powerful effects against B cell cancers, challenges exist in using them for solid tumors.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Medicine, General & Internal

How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches

Michele Ghidini et al.

Summary: Despite challenges in treating gastric cancer, immunotherapy may offer new hope. While predictive biomarkers exist, clinical implementation remains difficult.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Oncology

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

A. Bardia et al.

Summary: This study summarized the safety and efficacy data of using SG to treat patients with advanced epithelial cancers, identifying common treatment-related adverse events such as nausea, diarrhea, and fatigue. Neutropenia was more frequent in some patients, and efficacy was observed in multiple cancer cohorts.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Meeting Abstract Oncology

Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A

D. V. Catenacci et al.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Meeting Abstract Oncology

Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.

Yelena Y. Janjigian et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian et al.

Summary: Nivolumab plus chemotherapy showed superior overall survival and progression-free survival compared to chemotherapy alone in previously untreated patients with advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma, indicating it as a new standard first-line treatment option with acceptable safety profile.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer

Bihui Cao et al.

Summary: The study demonstrated that MSLN-CAR NK cells exhibit strong antitumor activity and can effectively kill MSLN-positive gastric cancer cells, showing promising therapeutic potential for gastric cancer treatment. Moreover, MSLN-CAR NK cells also significantly prolonged the survival of tumor-bearing mice in both subcutaneous and intraperitoneal tumor models, indicating their potent antitumor effects in vivo. Additionally, the observations of potent antitumor effects and significant NK cell infiltration in patient-derived xenografts treated with MSLN-CAR NK cells further supported the therapeutic efficacy of MSLN-CAR NK cells for gastric cancer.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Oncology

Single-cell profiling of infiltrating B cells and tertiary lymphoid structures in the TME of gastric adenocarcinomas

Lizhou Jia et al.

Summary: The study identified a substantial presence of MALT-B cells and NKT cells in gADC tissues, with MALT-B cells characterized by high expression of complement pathway activation genes.

ONCOIMMUNOLOGY (2021)

Add to Collection

Meeting Abstract Oncology

Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study

Aurelien Marabelle et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035

Melina Arnold et al.

GUT (2020)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017

Arash Etemadi et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Cell Biology

Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer

Gabriel Ascui et al.

IMMUNOLOGY AND CELL BIOLOGY (2020)

Add to Collection

Review Immunology

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Ombretta Melaiu et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Kohei Shitara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Oncology

Engineering CAR-T Cells for Next-Generation Cancer Therapy

Mihe Hong et al.

CANCER CELL (2020)

Add to Collection

Review Oncology

Tumor microenvironment in gastric cancers

Yukiko Oya et al.

CANCER SCIENCE (2020)

Add to Collection

Editorial Material Immunology

Editorial: NKT Cells in Cancer Immunotherapy

Tonya J. Webb et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Gastric cancer

Elizabeth C Smyth et al.

LANCET (2020)

Add to Collection

Article Oncology

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

Kohei Shitara et al.

JAMA ONCOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

CAR-NK cells: A promising cellular immunotherapy for cancer

Guozhu Xie et al.

EBIOMEDICINE (2020)

Add to Collection

Article Oncology

Immune Cell Infiltrate and Prognosis in Gastric Cancer

Niko Kemi et al.

CANCERS (2020)

Add to Collection

Meeting Abstract Hematology

Initial Clinical Activity of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma

Veronika Bachanova et al.

BLOOD (2020)

Add to Collection

Article Medicine, General & Internal

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation

Nana Zhang et al.

ARCHIVES OF MEDICAL SCIENCE (2020)

Add to Collection

Article Oncology

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurelien Marabelle et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital

Ryan Morgan et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2019)

Add to Collection

Article Oncology

Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer

Jiang Lv et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Add to Collection

Article Immunology

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah-Eddin Al-Batran et al.

LANCET (2019)

Add to Collection

Article Oncology

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

Filippo Pietrantonio et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

CD4/CD8+T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis

Fangxuan Li et al.

CANCER MEDICINE (2019)

Add to Collection

Review Oncology

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Funda Meric-Bernstam et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Immunology

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells

Sema Kurtulus et al.

IMMUNITY (2019)

Add to Collection

Review Immunology

Therapeutic Potential of Natural Killer Cells in Gastric Cancer

Yu Du et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Oncology

B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies

Hans A. Schloesser et al.

ONCOIMMUNOLOGY (2019)

Add to Collection

Article Cell Biology

Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer

Wei Li et al.

CELL DEATH & DISEASE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Current Progress in CAR-T Cell Therapy for Solid Tumors

Shuo Ma et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim et al.

NATURE MEDICINE (2018)

Add to Collection

Article Immunology

Tumor microenvironmental factors have prognostic significances in advanced gastric cancer

Bokyung Ahn et al.

APMIS (2018)

Add to Collection

Article Oncology

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Surgery

ImmunoScore Signature A Prognostic and Predictive Tool in Gastric Cancer

Yuming Jiang et al.

ANNALS OF SURGERY (2018)

Add to Collection

Article Oncology

The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer

Zhi-Hua Zhou et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)

Add to Collection

Article Cell Biology

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection

Shomyseh Sanjabi et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Add to Collection

Article Oncology

Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer

Xiaoli Ju et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma

Maria C. Svensson et al.

ONCOTARGET (2017)

Add to Collection

Review Oncology

Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities

An-Liang Xia et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer

Liu-sheng Peng et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Add to Collection

Review Oncology

Engineering CAR-T cells

Cheng Zhang et al.

BIOMARKER RESEARCH (2017)

Add to Collection

Article Multidisciplinary Sciences

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Se Jin Im et al.

NATURE (2016)

Add to Collection

Article Immunology

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

Thibault Voron et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Add to Collection

Article Chemistry, Medicinal

Upregulation of PD-LI and APEI is associated with tumorigenesis and poor prognosis of gastric cancer

Yi Qing et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2015)

Add to Collection

Review Immunology

The generation of antibody-secreting plasma cells

Stephen L. Nutt et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Add to Collection

Review Hematology

Current concepts in the diagnosis and management of cytokine release syndrome

Daniel W. Lee et al.

BLOOD (2014)

Add to Collection

Article Multidisciplinary Sciences

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass et al.

NATURE (2014)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Gastric Cancer: Overview

Pelayo Correa

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2013)

Add to Collection

Article Gastroenterology & Hepatology

Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer

Yonghui Wu et al.

GUT (2013)

Add to Collection

Article Oncology

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

Douglas Hanahan et al.

CANCER CELL (2012)

Add to Collection

Review Immunology

T Cells in Gastric Cancer: Friends or Foes

Amedeo Amedei et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Add to Collection

Review Oncology

Immune parameters affecting the efficacy of chemotherapeutic regimens

Laurence Zitvogel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

CELL (2010)

Add to Collection

Article Biotechnology & Applied Microbiology

Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-beta 1) in Patients with Gastric Cancer

Andrzej Szkaradkiewicz et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Add to Collection

Article Immunology

B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

David J. DiLillo et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung-Jue Bang et al.

LANCET (2010)

Add to Collection

Article Oncology

Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity

Hans-Georg Kopp et al.

CANCER RESEARCH (2009)

Add to Collection

Review Hematology

B lymphocytes: how they develop and function

Tucker W. LeBien et al.

BLOOD (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Macrophage activation and polarization

Fernando Oneissi Martinez et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.